CLINICAL_TRIALS
trial_result
· 2014-07-28
Clinical Trial Update: Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients [Phase 2]
Summary
Phase 2 clinical trial evaluating MBX-102 in combination with allopurinol for gout. The study is completed and results were posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gilead Sciences | Conditions: Gout | Phase 2 | Status: COMPLETED | Results posted: 2014-07-28